PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Long-term users of ecstasy risk structural brain damage

Preliminary evidence of hippocampal damage in chronic users of ecstasy

2011-04-07
(Press-News.org) Long term users of the popular recreational drug ecstasy (MDMA) risk structural brain damage, suggests preliminary research published online in the Journal of Neurology, Neurosurgery and Psychiatry.

Other research has suggested that people who use ecstasy develop significant memory problems, so the Dutch researchers wanted to find out if there was any clinical evidence of structural changes in the brain to back this up.

They focused on the hippocampus, which is the area of the brain responsible for long term memory.

They measured the volume of the hippocampus using MRI scans in 10 young men in their mid 20s who were long term users of ecstasy and seven of their healthy peers in their early 20s with no history of ecstasy use.

Although the ecstasy group had used more amphetamine and cocaine than their peers, both sets of young men had used similar amounts of recreational drugs, bar ecstasy, and drank alcohol regularly.

The ecstasy group had not been using on average for more than two months before the start of the study, but had taken an average of 281 ecstasy tablets over the preceding six and a half years.

The MRI scans showed that hippocampal volume in this group was 10.5% smaller than that of their peers, and the overall proportion of grey matter was on average 4.6% lower, after adjusting for total brain volume.

This indicates that the effects of ecstasy may not be restricted to the hippocampus alone, say the authors

"Taken together, these data provide preliminary evidence suggesting that ecstasy users may be prone to incurring hippocampal damage, following chronic use of this drug," they write.

They add that their findings echo those of other researchers who have reported acute swelling and subsequent atrophy of hippocampal tissue in long term ecstasy users.

And they point out: "Hippocampal atrophy is a hallmark for diseases of progressive cognitive impairment in older patients, such as Alzheimer's disease.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Four Out of Five Community Hospitals Pin HITECH Hopes on Current Electronic Medical Records

2011-04-07
Electronic medical records (EMRs) are garnering deeper use in the community hospital scene, and nearly all have been certified HITECH-ready by an official certification body. Nevertheless, a fifth of these hospitals plan to switch EMR products within the next couple of years -- even this close to meaningful use (MU) deadlines -- according to a new report by KLAS. For the new report, "Community Hospital EMRs Maturing for Meaningful Use," KLAS interviewed more than 500 healthcare professionals about their experience with various EMR systems. Of respondents, 80 percent ...

Regular retail therapy prolongs life

2011-04-07
A spot of regular retail therapy really does seem to help people live longer, suggests research published online in the Journal of Epidemiology and Community Health. And it seems to benefit older men the most, the findings show. The authors base their findings on almost 1,850 elderly (65+) Taiwanese people who were living independently at home, and included in the nationally representative Elderly Nutrition and Health Survey in Taiwan (NAHSIT Elderly), carried out in 1999-2000. Participants were asked how often they went shopping, with options ranging from "never" ...

Epileptic seizures linked to significant risk of subsequent brain tumor

2011-04-07
Epileptic seizures can precede the development of a subsequent brain tumour by many years, suggests research published online in the Journal of Neurology, Neurosurgery and Psychiatry. The risk seems to be greatest among those aged between 15 and 44 when first admitted to hospital for an epileptic seizure, the findings show. The researchers base their findings on first time admissions for epilepsy from the Oxford Record Linkage Study (ORLS) for 1963 to 1998, and national Hospital Episode Statistics (HES) data for England for 1999 to 2005. These data were then linked ...

FinancialSpreads.com Adds Differential Spread Betting Markets

FinancialSpreads.com Adds Differential Spread Betting Markets
2011-04-07
Financial Spreads, the UK-based spread betting company, has introduced another set of improvements for their clients. This year Financial Spreads have already tightened their spreads on a number of popular markets in order to lower the cost of trading for clients. They have also introduced Guaranteed Stops in order to help clients with their risk management. The spread betting company has now introduced 'differential markets'. Financial Spreads Spokesperson Adam Jepsen says that introducing differential markets not only offers account holders more choice, but better ...

Antibiotic-resistant bacteria in Indian public water supply

2011-04-07
Disease-causing bacteria carrying the new genetic resistance to antibiotics, NDM-1, have been discovered in New Delhi's drinking water supply. A Cardiff University-led team found new strains of resistant bacteria in the Indian capital, including species which cause cholera and dysentery. The findings are the first evidence of the environmental spread of NDM-1, which had previously only been found in hospitals. The scientists are calling for urgent action by health authorities worldwide to tackle the new strains and prevent their global spread. The Cardiff scientists ...

Researchers find link between common dietary fat, intestinal microbes and heart disease

2011-04-07
A new pathway has been discovered that links a common dietary lipid and intestinal microflora with an increased risk of heart disease, according to a Cleveland Clinic study published in the latest issue of Nature. The study shows that people who eat a diet containing a common nutrient found in animal products (such as eggs, liver and other meats, cheese and other diary products, fish, shellfish) are not predisposed to cardiovascular disease solely on their genetic make-up, but rather, how the micro-organisms that live in our digestive tracts metabolize a specific lipid ...

Researchers ID microbe responsible for methane from landfills

2011-04-07
Researchers have long known that landfills produce methane, but had a hard time figuring out why – since landfills do not start out as a friendly environment for the organisms that produce methane. New research from North Carolina State University shows that one species of microbe is paving the way for other methane producers. Specifically, the researchers found that an anaerobic bacterium called Methanosarcina barkeri appears to be the key microbe. "Landfills receive a wide variety of solid waste, and that waste generally starts out with a fairly low pH level," says ...

Neural guidance gene regulates liver development

2011-04-07
Scientists of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch (Germany) have demonstrated for the first time that a gene regulating neuronal cell migration during embryogenesis also plays a role in the development of the liver. Using zebrafish as a model organism, Dr. Christian Klein and Professor Ferdinand le Noble showed that the gene navigator-3 (abbreviated nav3a) regulates liver organogenesis. If nav3a is missing, the liver cannot develop (Development 2011, doi:10.1242/dev.056861)*. "Moreover, first evidence indicates," Dr. Klein said, "that the expression ...

Most recent mammography recommendations confuse public

2011-04-07
San Diego, CA, April 6, 2011 – When the U.S. Preventive Services Task Force (USPSTF), an independent panel of experts in primary care and prevention, released its recommendations on mammography screenings for US women on November 16, 2009, there was immediate and considerable controversy. In a study published in the May 2011 issue of the American Journal of Preventive Medicine, investigators report that these new recommendations confused women (30.0%) more than they helped them understand when to get a mammogram (6.2%). Confusion was greatest among women aged 40-49 years ...

New drug shrinks cancer in animals, U-M study shows

2011-04-07
ANN ARBOR, Mich. — A study led by researchers at the University of Michigan Comprehensive Cancer Center showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects. The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppressor function. This allows the tumor to grow unchecked. The new ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Long-term users of ecstasy risk structural brain damage
Preliminary evidence of hippocampal damage in chronic users of ecstasy